Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shigeri

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Life Sciences|September 25, 1998
A potent nonpeptide neuropeptide Y Y1 receptor antagonist, a benzodiazepine derivativeY Shigeri, M Ishikawa, Y Ishihara, et al.
European Journal of Pharmacology|May 14, 1992
Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aortaM Fujimoto, S Mihara, Y Shigeri, et al.
British Journal of Pharmacology|May 6, 2008
Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatasesA Ishida, N Sueyoshi, Y Shigeri, et al.
Biochemical and Biophysical Research Communications|October 23, 1996
Solid-phase synthesis of caged peptides using tyrosine modified with a photocleavable protecting group: application to the synthesis of caged neuropeptide YY Tatsu, Y Shigeri, S Sogabe, et al.
Japanese Journal of Pharmacology|September 1, 1996
Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampusY Shigeri, S Shinohara, S Murata, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncationM Shimizu, Y Shigeri, Y Tatsu, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis of caged peptides using caged lysine: application to the synthesis of caged AIP, a highly specific inhibitor of calmodulin-dependent protein kinase IIY Tatsu, Y Shigeri, A Ishida, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptorsM Horikawa, Y Shigeri, N Yumoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductanceR P Seal, Y Shigeri, S Eliasof, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2000
Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockersK Shimamoto, Y Shigeri, Y Yasuda-Kamatani, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Life Sciences|September 25, 1998
A potent nonpeptide neuropeptide Y Y1 receptor antagonist, a benzodiazepine derivativeY Shigeri, M Ishikawa, Y Ishihara, et al.
European Journal of Pharmacology|May 14, 1992
Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aortaM Fujimoto, S Mihara, Y Shigeri, et al.
British Journal of Pharmacology|May 6, 2008
Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatasesA Ishida, N Sueyoshi, Y Shigeri, et al.
Biochemical and Biophysical Research Communications|October 23, 1996
Solid-phase synthesis of caged peptides using tyrosine modified with a photocleavable protecting group: application to the synthesis of caged neuropeptide YY Tatsu, Y Shigeri, S Sogabe, et al.
Japanese Journal of Pharmacology|September 1, 1996
Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampusY Shigeri, S Shinohara, S Murata, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncationM Shimizu, Y Shigeri, Y Tatsu, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis of caged peptides using caged lysine: application to the synthesis of caged AIP, a highly specific inhibitor of calmodulin-dependent protein kinase IIY Tatsu, Y Shigeri, A Ishida, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptorsM Horikawa, Y Shigeri, N Yumoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductanceR P Seal, Y Shigeri, S Eliasof, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2000
Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockersK Shimamoto, Y Shigeri, Y Yasuda-Kamatani, et al.
Pageof 3